This core unit is located within the administrative offices at the Blood Research Institute, the research arm of the Blood Center of Southeastern Wisconsin. The BRI includes the offices and laboratories of the pediatric hematology faculty of the Department of Pediatrics at MCW, and is the location of the Comprehensive Center for Bleeding Disorders. This administrative core will coordinate this multifaceted program and consists of two major components. The first is providing the administrative coordination scientific leadership to the project leaders and their coinvestigators. It will utilize both an Executive Committee and an External Advisory Committee to guide this function as described in greater detail in the introduction to this program project. Two meetings a year will be organized for the Pi's and co-Pi's as well as the Directors of the primary clinical centers. One of these will be a brief one half-day meeting held in conjunction with the American Society of Hematology meeting in December of each year and the second will be a two day meeting held in Milwaukee for the investigator group of this PPG. A second major task of this administrative core is to provide a central site for receiving patient samples from the Primary Clinical Centers as well as their data entry forms. Core A will oversee data entry, quality control and validation of data from the primary (and secondary) clinical centers. These will be described separately.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL081588-05
Application #
7885358
Study Section
Special Emphasis Panel (ZHL1)
Project Start
Project End
2012-02-14
Budget Start
2009-07-01
Budget End
2012-02-14
Support Year
5
Fiscal Year
2009
Total Cost
$678,996
Indirect Cost
Name
Medical College of Wisconsin
Department
Type
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Flood, Veronica H; Abshire, Thomas C; Christopherson, Pamela A et al. (2018) Von Willebrand disease in the United States: perspective from the Zimmerman program. Ann Blood 3:
Mufti, Ahmad H; Ogiwara, Kenichi; Swystun, Laura L et al. (2018) The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance. Blood Adv 2:1585-1594
Jacobi, P M; Kanaji, S; Jakab, D et al. (2018) von Willebrand factor propeptide to antigen ratio identifies platelet activation and reduced von Willebrand factor survival phenotype in mice. J Thromb Haemost 16:546-554
Szederjesi, A; Baronciani, L; Budde, U et al. (2018) An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study. J Thromb Haemost :
Selvam, Soundarya N; Casey, Lara J; Bowman, Mackenzie L et al. (2017) Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients. Blood Coagul Fibrinolysis 28:521-533
Baumgartner, C K; Mattson, J G; Weiler, H et al. (2017) Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice. J Thromb Haemost 15:98-109
Selvam, Soundarya; James, Paula (2017) Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science. Semin Thromb Hemost 43:572-580
Lorenz, Viola; Ramsey, Haley; Liu, Zhi-Jian et al. (2017) Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice. Thromb Haemost 117:2322-2333
Bowman, M L; Pluthero, F G; Tuttle, A et al. (2017) Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24. J Thromb Haemost 15:1403-1411
Doruelo, A L; Haberichter, S L; Christopherson, P A et al. (2017) Clinical and laboratory phenotype variability in type 2M von Willebrand disease. J Thromb Haemost 15:1559-1566

Showing the most recent 10 out of 120 publications